Biotech ETFs Jump on Gilead, Kite Deal
August 28, 2017 at 14:37 PM EDT
The biotechnology segment rallied Monday with small-cap biotech names and related exchange traded funds leading the charge after Gilead Sciences (NasdaqGS: GILD) acquired Kite Pharma (NasdaqGS: KITE). The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotechnology exchange traded...
